Previous Page  7 / 21 Next Page
Information
Show Menu
Previous Page 7 / 21 Next Page
Page Background

Page 25

Notes:

allied

academies

August 14-16, 2017 | Toronto, Canada

BRAIN DISORDERS AND DEMENTIA CARE

4

th

International Conference on

Neurosurg, an open access journal

ISSN: 2471-9633

To evaluate the effectiveness of BOTOX (Botulinum Toxin Type A) in the treatment of focal spasticity

among geriatric stroke survivors

Janusz A. Kaleta

Manhattan Nursing Services PLLC, USA

Relevance:

Spasticity is a common challenge encountered

post stroke by survivors, families as well as therapists,

nurses and other health care professionals get involved in

treatment of stroke survivors. Dependent on the severity,

spasticity can lead to serious debilitating conditions such as

pain, stiffness, rigidity and inability to participate in essential

activities of daily living as well as in therapy. Spasticity

as well as muscular overactivity frequently has profound

impact on lives of stroke survivors. Although conventional

Physical Medicine and Rehabilitation offers interventions

for spasticity management there is a continuous search into

new ways to combat spasticity more effectively and to allow

for greater recovery and independence of stroke survivors.

Stroke is a leading cause for transfers into Long Term Care

Homes. Geriatric stroke survivors are often confronted with

greater severities of post stroke complications including

spasticity and therefore need a proper approach geared

towards that population.

Methods:

Review of evidence on BOTOX (Botulinum Toxin

Type A) clinical application, safety and effectiveness was

conducted. Spasticity program combining evidence based

guidelines for stroke rehabilitation and use of BOTOX was

developed in Long Term Care Home. Twelve geriatric stroke

survivors and one client with diagnosis of cerebral palsy were

assessed by Physiatrist. Client, families and interdisciplinary

team was involved in active collaboration. Based on

comprehensive assessment four stroke survivors received

BOTOX injections in addition to conventional therapy

received from a Physiotherapist and Rehabilitation staff.

All clients were also encouraged to participate in offered

activation therapy that combines movement, self-expression

and discussions. The 4 Point Disability Assessment Scale was

used to assess effectiveness of BOTOX in conjunction with

traditional physiotherapy treatment.

Results:

The spasticity program combining conventional

rehabilitation practices and use of BOTOX demonstrated

marked improvements in ROM, decrease in pain and rigidity,

improved comfort/positioning, ability to participate in

physiotherapy and basic activities of daily living. The results

were measured with use of the 4 Point Disability Assessment

Scale (DAS).

Findings:

Geriatric stroke survivors with focal spasticity

were able to regain greater mobility and functionality

post participation in BOTOX treatment in conjunction with

traditional physiotherapy. Spasticity clinics and or access to

Physiatrist could effectively alleviate disabling impact of this

post stroke condition on Geriatric stroke survivors.

Discussion/Conclusion:

While stroke survivor enters

acute care and spends weeks in rehabilitation setting large

percentage of geriatric stroke survivors spend months, years

or decades within Long Term Care. At such there is a need

to heightened sector awareness for specialty services that

should be available to geriatric stroke survivors.

Speaker Biography

Janusz Kaleta works at Patient's safety and risk management as a specialist at Human

Restauro in New York City, USA

e:

jkaleta@uwo.ca

Janusz A. Kaleta, Neurosurg 2017, 2:2

DOI: 10.21767/2471-9633-C1-005